Find investors
← Back to all investors
Ben Chang
ResearchedAngel Investors

Ben Chang

Angel InvestorsSeed Round
Pitch Ben

Get their honest, personalized take on your startup.

Sign in to pitch Ben

At a glance

Full Name
P.H. Benjamin “Ben” Chang
Title
Managing Director
Firm
Consilium Partners LLC
Firm Type
Middle-market investment banking advisory firm
Investment Stage
Growth capital; control and growth-capital investments through prior merchant-banking work
Target Company Profile
Middle-market companies seeking M&A advisory, private placements, growth equity, mezzanine debt, senior debt, acquisition financing, strategic investment, recapitalizations, or exit preparation
Sector Focus
Healthcare; flavor technologies; healthcare services; business services; consumer products; niche manufacturers and distributors
Geographic Focus
United States; Consilium also works through Globalscope for cross-border buyer and investor access
Location
Boston, Massachusetts

Background

Ben Chang is a Managing Director at Consilium Partners LLC, a Boston-based investment banking advisory firm focused on middle-market transactions. Consilium describes its work as sector-specialized middle-market advisory, including sell-side and buy-side M&A, growth capital, recapitalizations, divestitures, acquisition financing, and strategic advisory.

Chang has more than 20 years of investment banking and private equity investment experience. Consilium states that he has completed more than 60 transactions totaling nearly $1 billion in value. Before joining Consilium, he founded and served as Managing Principal of Wellfleet Capital Partners, a healthcare-focused merchant bank that worked with management teams on control and growth-capital investments; during that period, he was a director or investor in 10 companies.

Earlier in his career, Chang was a Senior Healthcare Investment Banker at Advest, Inc., an Associate at Ferris, Baker Watts, and worked with Security Pacific Merchant Bank. He has served as a Director of MicroChem Corp., Summit Service Group, Inc., Fabreeka International, Inc., and Buyrite Designs, Inc. He is proficient in Mandarin Chinese and has been a member of the Brookline, Massachusetts School Committee.

Chang earned a B.A. in Economics and International Relations from Tufts University and an MBA in Finance from Duke University’s Fuqua School of Business. He holds FINRA Series 79 and 63 licenses.

Investment Thesis & Focus

  • Chang’s current work is best characterized as middle-market investment banking advisory rather than disclosed angel investing. I found no primary-source evidence supporting the stub’s “Angel Investors” or “Seed Round” classification.
  • His sector focus at Consilium is healthcare and flavor technologies, with broader experience in healthcare services, flavor technologies, business services, consumer products, and niche manufacturers and distributors.
  • His prior Wellfleet Capital Partners work focused on healthcare merchant banking, specifically partnering “with management teams in making control and growth capital investments.”
  • Consilium’s growth-capital service areas include growth equity, mezzanine debt, senior debt, acquisition financing, and strategic investment.
  • For healthcare, Consilium highlights community-based care and services, outsourced services, healthcare IT, managed care, medical devices, research tools and technologies, and contract design and manufacturing.
  • For flavor technology, Consilium highlights sweet and savory flavors, spices and seasoning, stocks and soups, and coatings, sauces, and marinades.

Notable Investments

  • All-At-Home Health Care LLC — Consilium advised the company on its acquisition by Webster Equity Partners; sell-side advisory in healthcare.
  • DoseSpot — Consilium advised DoseSpot on a growth investment from Providence Strategic Growth.
  • Quality Life Adult Day Service — Consilium advised the company on its acquisition by The MENTOR Network.
  • CM Group — Consilium advised the company on a recapitalization through an investment by NaviMed Capital.
  • MicroChem Corp. — Chang is listed among Consilium’s representative transactions advising MicroChem on its acquisition of Conductive Compounds Inc. and Paratronix, Inc.; he also served as a Director of MicroChem.
  • Foreign Exchange Translations — Consilium advised the company on its sale to euroscript international.
  • Brand Aromatics, Inc. — Consilium advised the company on its sale to McCormick & Co. Inc.
  • Valley Psychiatric Service — Consilium advised the company on its sale to Providence Service Corporation.
  • Mass ADH Alliance — Consilium advised the organization on its sale to The Mentor Network.
  • Synergy Flavors — Consilium advised Synergy Flavors on acquisitions of Sethness Greenleaf, Sensus, Vanlabs, and U.S. Flavors and Fragrances.
  • Senior Whole Health — Consilium advised the company on capital-raising from several private equity firms.
  • American Medical Response — Consilium advised the company on capital raising and several add-on acquisitions.

Unlock the full research

Get how to approach them, recent activity, sources, contact links — plus pitch their AI twin for a candid read on your raise.

One-time. Stays unlocked for you.